Department of Internal Medicine, Niigata University Faculty of Medicine, 1-757, Asahimachi, 951-8510 Niigata, Japan.
Japan Medical Data Center Co., Ltd., 2-5-5, Shibadaimon, 105-0012 Tokyo, Japan.
Diabetes Metab. 2017 Dec;43(6):543-546. doi: 10.1016/j.diabet.2017.08.002. Epub 2017 Sep 14.
This study aimed to examine the impact of obesity, as defined by body mass index (BMI), and a metabolically unhealthy phenotype on the development of coronary artery disease (CAD) according to glucose tolerance status.
This population-based retrospective cohort study included 123,746 Japanese men aged 18-72years (normal glucose tolerance: 72,047; prediabetes: 39,633; diabetes: 12,066). Obesity was defined as a BMI≥25kg/m. Metabolically unhealthy individuals were defined as those with one or more of the following conditions: hypertension, hypertriglyceridaemia and/or low HDL cholesterol. A Cox proportional hazards regression model identified variables related to CAD incidence.
The prevalences of obese subjects with normal glucose tolerance, prediabetes and diabetes were 21%, 34% and 53%, whereas those for metabolically unhealthy people were 43%, 60% and 79%, respectively. Multivariate analysis showed that a metabolically unhealthy phenotype increases hazard ratios (HRs) for CAD compared with a metabolically healthy phenotype, regardless of glucose tolerance status (normal glucose tolerance: 1.98, 95% CI: 1.32-2.95; prediabetes: 2.91, 95% CI: 1.85-4.55; diabetes: 1.90, 95% CI: 1.18-3.06). HRs for CAD among metabolically unhealthy non-obese diabetes patients and obese diabetes patients with a metabolically unhealthy status were 6.14 (95% CI: 3.94-9.56) and 7.86 (95% CI: 5.21-11.9), respectively, compared with non-obese subjects with normal glucose tolerance and without a metabolically unhealthy status.
A metabolically unhealthy state can associate with CAD independently of obesity across all glucose tolerance stages. Clinicians may need to consider those with at least one or more conditions indicating a metabolically unhealthy state as being at high risk for CAD regardless of glucose tolerance status.
本研究旨在根据葡萄糖耐量状态,探讨肥胖(以体质指数 BMI 定义)和代谢不健康表型对冠心病 CAD 发展的影响。
本基于人群的回顾性队列研究纳入了 123746 名 18-72 岁的日本男性(正常糖耐量:72047 人;糖尿病前期:39633 人;糖尿病:12066 人)。肥胖定义为 BMI≥25kg/m。代谢不健康个体定义为存在以下一种或多种情况:高血压、高三酰甘油血症和/或低高密度脂蛋白胆固醇。采用 Cox 比例风险回归模型确定与 CAD 发生率相关的变量。
正常糖耐量、糖尿病前期和糖尿病患者中肥胖者的患病率分别为 21%、34%和 53%,而代谢不健康者的患病率分别为 43%、60%和 79%。多变量分析显示,无论葡萄糖耐量状态如何,代谢不健康表型比代谢健康表型都会增加 CAD 的危险比(HR)(正常糖耐量:1.98,95%CI:1.32-2.95;糖尿病前期:2.91,95%CI:1.85-4.55;糖尿病:1.90,95%CI:1.18-3.06)。与非肥胖、正常糖耐量且无代谢不健康状态的个体相比,代谢不健康的非肥胖糖尿病患者和代谢不健康的肥胖糖尿病患者的 CAD 危险比分别为 6.14(95%CI:3.94-9.56)和 7.86(95%CI:5.21-11.9)。
无论葡萄糖耐量状态如何,代谢不健康状态均可与肥胖一起独立导致 CAD。临床医生可能需要考虑那些至少有一个或多个表明代谢不健康状态的条件的患者为 CAD 高危人群,而无论其葡萄糖耐量状态如何。